3. Brunton L.L., Chabner B.A., Knollmann B.C. Pharmacotherapy of the epilepsies, In: Goodman & Gilman's The Pharmacological Basis of Therapeutics (O. M. James, Eds.) 12th Edn., New Delhi: McGraw-Hill, 2010.
6. Supran C.T., Scozzafava A., Daniela V., Montero J.L., Gangard V., Innocenti A., Winum J.Y. Bioorg. Med. Chem. Lett. 2005, 15(6), 1653.
7. Christianson D.W. Rigaku J., 1996, 13(1), 8-15.
11. Onkol T., Cakir B., Sahin M.F., Yildirim E., Erol K. Turk. J. Chem. 2004, 28, 461-468.
14. Shukla S.K., Singh S.P., Nautiyal S.R., Mukherjee D.D. Indian Drugs 1982, 20, 21.
15. Saksena R.K., Puri S., Prakash R. J. Heterocycl. Chem. 2003, 13(2), 127-130.
16. Hanna M.A., Girges M.M., Rasala D., Gawinecki R. Arzeneim-Forsch Drug Res. 1995, 45(10), 1074-1078.
17. Cross P.E., Dickinson P.R. Chem. Abstr. 1978, 88, 190839t.
18. Zuhair M.E., Fuad A.J., Shamis E., Sabah A.K., Hanan G., Murfied G. Chem. Abstr. 1983, 98, 72006c.
19. Nizamuddin, Singh A. Indian J. Chem. 2004, 43B, 901-905.
20. Ward J.S. Chem. Abstr. 1977, 87, 201546c.
21. Zhang Y.X., Xua W.T. Chem. Abstr. 1996, 124(23), 317071f.
22. Taranalli A.D., Ahmed A., Patil B.M. Indian Drugs, 1995, 29(14), 643-648.
27. Vogel’s Textbook of Practical Organic Chemistry, (Furniss B.S., Hannaford A.J., Smith P.W.G., Tatchell A.R. Eds.) 5th Edn., London: ELBS Publications, 1996, p. 1273.
28. Martin Y.C. Theoretical Basis of Medicinal Chemistry: Structure Activity Relationship and Three Dimensional Structures of Small and Macromolecules, In: Modern Drug Research, Path to Better and Safer Drugs (Martin Y.C., Austel V., Kutter E. Eds.) New York: Marcel Dekker, 1989, p. 161.
29. McForland J.W., Gans D.J. Comprehensive Medicinal Chemistry 3, Oxford: Pergamon Press, 1990, p. 667.
32. Dimmock J.R., Sidhu K.K., Tumber S.D., Basran S.K., Chen M., Quail J.W., Yang J., Rozas I., Weaver D.F. Eur. J. Med. Chem. 1995, 30, 287-301.
http://dx.doi.org/10.1016/0223-5234(96)88237-7
33. Burgers Medicinal Chemistry and Drug Discovery Principle and Practice, Vol.1, (Kubinyi H., Wolff M.E. Eds.) 5th Edn, New York: Wiley Interscience Publication, 1995, p. 505.
34. CS Chem Office, Version 6.0, Cambridge Soft Corporation, Software Publisher Association, 1730 M Street, NW, Suite 700, Washington DC, 20036 (202), 452-1600, USA.
35. SYSTAT 10.2 version supplied by SYSTAT SOFTWARE INC.
36. Gupta A.K., Babu M.A., Kaskhedikar S.G. Ind. J. Pharm. Sci. 2004, 66, 396-402.
37. Perun T.J., Propst C.L., Computer Aided Drug Design Methods and Applications, Marcel Decker Inc: New York, 1989, p. 2.
38. Gerhard K., Abrahum U. J., Computer Aided Molecular Designs 1999, 22, 473.
40. Balakrishnan S., Pandhi P., Bhargava V.K. Ind. J. Exp. Biol. 1998, 36, 51-54.
PMid:9536652
41. Principles of Medicinal Chemistry, (Foye W.O. Eds.), 3rd Edn., Bombay: Verghese Publishing House, 1989, p. 173.
42. Khosla P., Pandhi P. Ind. J. Pharmacol. 2001, 33, 208-211.
43. Lipschitz W.L., Hadian, Kerpscas A. J. Pharmcol. Exp. Ther. 1943, 79, 97-110.
44. Grover J.K. Anticonvulsant, In: Experiments in Pharmacy and Pharmacology, Vol II, New Delhi: CBS Publishers and Distributors, 1990, p. 162.
45. Jain S.K., Mishra P. Ind. J. Chem. 2004, 43B, 184-188.
46. Jain S.K., Mishra P., Chem. Abstr. 2004, 140, 287334e.